borderline significanceP = 0.069
Gender status, concomitant urothelial carcinoma in situ, and the presence of tumor necrosis did not reach significance regarding DFS and CSS, with borderline significance regarding the response to BCG treatment ( P = 0.069) (Table 2 ).